推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-34243363

chinasupport@letpub.com

登录 注册 新注册优惠

CANCER INVESTIGATION

2024年6月最新影响因子数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

按期刊名首写字母查看 CANCER INVEST最新评论:应该是接收了才收的版面费吧 7000美元 (2024-03-07)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中国科学院分区:   是否OA期刊:   结果排序:

同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


CANCER INVESTIGATION期刊基本信息Hello,您是该期刊的第36734位访客


基本信息 登录收藏
期刊名字CANCER INVESTIGATIONCANCER INVESTIGATION

CANCER INVEST
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
5.3
51人评分
我要评分

声誉
6.4

影响力
3.9

速度
8.7

期刊ISSN0735-7907
微信扫码收藏此期刊
E-ISSN1532-4192
2023-2024最新影响因子
(数据来源于搜索引擎)
1.8 点击查看影响因子趋势图
实时影响因子 截止2024年3月26日:1.698
2023-2024自引率0.00%点击查看自引率趋势图
五年影响因子2.1
JCI期刊引文指标 0.39
h-index 77
CiteScore
2024年最新版
CiteScoreSJRSNIPCiteScore排名
3.800.6040.472
学科分区排名百分位
大类:Medicine
小类:Oncology
Q3217 / 404
大类:Medicine
小类:Cancer Research
Q3160 / 230

期刊简介
Cancer Investigation is one of the most highly regarded and recognized journals in the field of basic and clinical oncology. It is designed to give physicians a comprehensive resource on the current state of progress in the cancer field as well as a broad background of reliable information necessary for effective decision making. In addition to presenting original papers of fundamental significance, it also publishes reviews, essays, specialized presentations of controversies, considerations of new technologies and their applications to specific laboratory problems, discussions of public issues, miniseries on major topics, new and experimental drugs and therapies, and an innovative letters to the editor section. One of the unique features of the journal is its departmentalized editorial sections reporting on more than 30 subject categories covering the broad spectrum of specialized areas that together comprise the field of oncology. Edited by leading physicians and research scientists, these sections make Cancer Investigation the prime resource for clinicians seeking to make sense of the sometimes-overwhelming amount of information available throughout the field. In addition to its peer-reviewed clinical research, the journal also features translational studies that bridge the gap between the laboratory and the clinic.
期刊官方网站http://www.tandfonline.com/toc/icnv20/current#.V4hzokz9cSQ
期刊投稿网址https://mc.manuscriptcentral.com/lcnv
期刊语言要求经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足CANCER INVESTIGATION的语言要求,还能让CANCER INVESTIGATION编辑和审稿人得到更好的审稿体验,让稿件最大限度地被CANCER INVESTIGATION编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢
提交文稿
是否OA开放访问No
通讯方式TAYLOR & FRANCIS INC, 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, USA, PA, 19106
出版商Informa Healthcare
涉及的研究方向医学-肿瘤学
出版国家或地区UNITED STATES
出版语言English
出版周期Bimonthly
出版年份1983
年文章数 53点击查看年文章数趋势图
Gold OA文章占比7.62%
研究类文章占比:
文章 ÷(文章 + 综述)
83.02%
WOS期刊SCI分区
2023-2024年最新版
WOS分区等级:3区

按JIF指标学科分区收录子集JIF分区JIF排名JIF百分位
学科:ONCOLOGYSCIEQ3241/322
按JCI指标学科分区收录子集JCI分区JCI排名JCI百分位
学科:ONCOLOGYSCIEQ4246/322
中国科学院《国际期刊预警
名单(试行)》名单
2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
中国科学院SCI期刊分区
2023年12月最新升级版
点击查看中国科学院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 1区4区4区
ONCOLOGY
肿瘤学
3区4区4区
中国科学院SCI期刊分区
2022年12月升级版
大类学科小类学科Top期刊综述期刊
医学 2区4区2区
ONCOLOGY
肿瘤学
1区4区4区
中国科学院SCI期刊分区
2021年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 2区4区1区
ONCOLOGY
肿瘤学
2区1区4区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0735-7907%5BISSN%5D
平均审稿速度网友分享经验:
平均8.5月
平均录用比例网友分享经验:
约50%
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在CANCER INVESTIGATION顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
期刊常用信息链接
同领域相关期刊 CANCER INVESTIGATION期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 CANCER INVESTIGATION中国科学院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
CANCER INVESTIGATION上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中国科学院分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发文
  • 中国科学院分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144873.20
    Nature Reviews Clinical Oncology12799.40
    NATURE REVIEWS CANCER396111.90
    ANNALS OF ONCOLOGY21063.90
    CANCER CELL29555.20
    JOURNAL OF CLINICAL ONCOLOGY49441.20
    LANCET ONCOLOGY27462.10
    CANCER RESEARCH41116.10
    SEMINARS IN CANCER BIOLOGY13426.80
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH6718.20
    中国科学院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE635536
    BIOMATERIALS538820
    BIOMEDICINE & PHARMACOTHERAPY504813
    Frontiers in Pharmacology481335
    Journal of Materials Chemistry B479586
    Frontiers in Immunology455407
    JOURNAL OF ETHNOPHARMACOLOGY433213
    COMPUTERS IN BIOLOGY AND MEDICINE420588
    COLLOIDS AND SURFACES B-BIOINTERFACES420194
    Frontiers in Oncology409341
  •  

    CANCER INVESTIGATION CANCER INVESTIGATION
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.Trends and Projections of Stomach Cancer Incidence in Hong Kong: A Population-Based Study

    Author: Yang, Liping; Sun, Haifeng; Bai, Yan; Sun, Shengzhi; Wu, Xiaoming; Gan, Zhenhai; Du, Jianqiang; Du, Jianfei
    Journal: CANCER INVESTIGATION. 2023; Vol. 41, Issue 4, pp. 319-329. DOI: 10.1080/07357907.2022.2126982
        PubMed      DOI
    2.Tumoral Overexpression of Hepcidin is Associated with Poor Prognosis of Patients with Clear Cell Renal Cell Carcinoma

    Author: Qiu, Huizhu; Gu, Guojian; Zuo, Erdong; Cheng, Xu
    Journal: CANCER INVESTIGATION. 2023; Vol. 41, Issue 1, pp. 84-92. DOI: 10.1080/07357907.2022.2133775
        PubMed      DOI
    3.The Prognostic Value of ADAMTS8 and Its Role as a Tumor Suppressor in Breast Cancer

    Author: Zhang, Qia; Kanyomse, Quist; Luo, Chenghao; Mo, Qingfan; Zhao, XunPing; Wang, Long; Peng, Weiyan; Ren, Guosheng
    Journal: CANCER INVESTIGATION. 2023; Vol. 41, Issue 2, pp. 119-132. DOI: 10.1080/07357907.2022.2128367
        PubMed      DOI
    4.A DNA Damage Response Related Signature to Predict Prognosis in Patients with Acute Myeloid Leukemia

    Author: Wang, Jun; Wu, Jiafei; Wang, Yijing; Wang, Yu; Jiang, Chuanyan; Zou, Mengying; Jin, Xiaokang; Sun, Xiaoran; Zhang, Yu; Ma, Sijia; Wang, Guoqiang; Zhu, Xin; Lu, Huafei; Xu, Chunwei; Wang, Wenxian; Li, Leo; Han, Yusheng; Cai, Shangli; Li, Hui
    Journal: CANCER INVESTIGATION. 2023; Vol. 41, Issue 3, pp. 271-283. DOI: 10.1080/07357907.2023.2167209
        PubMed      DOI
    5.Efficacy and Safety of Bevacizumab for Treating Glioblastoma: A Systematic Review and Meta-Analysis of Phase II and III Randomized Controlled Trials

    Author: Xie, Xiaohong; Bao, Shangyi; Zhao, Hong; Li, Liuying; Fu, Xiaojun
    Journal: CANCER INVESTIGATION. 2023; Vol. 41, Issue 3, pp. 305-317. DOI: 10.1080/07357907.2023.2174261
        PubMed      DOI
    6.Poorly Controlled Diabetes Mellitus Increases the Risk of Deaths and Castration-Resistance in Locally Advanced Prostate Cancer Patients

    Author: Ma, Cheng; Cui, Di; Han, Bangmin; Ding, Mao; Zhang, Jiahao; Liu, Shiyun; Gao, Yingli; Xia, Shujie
    Journal: CANCER INVESTIGATION. 2023; Vol. 41, Issue 4, pp. 345-353. DOI: 10.1080/07357907.2023.2171050
        PubMed      DOI
    7.Identification and Validation of Molecular Subtype and Prognostic Signature for Bladder Cancer Based on Neutrophil Extracellular Traps

    Author: Tu, Yaofen; Mao, Zujie
    Journal: CANCER INVESTIGATION. 2023; Vol. 41, Issue 4, pp. 354-368. DOI: 10.1080/07357907.2023.2179063
        PubMed      DOI
    8.Bioinformatics Identification and Validation of Aging-Related Molecular Subtype and Prognostic Signature in Sarcoma

    Author: Hong, Xu; Liu, Hui; Chen, Chu; Lai, Tian; Lin, Jingui
    Journal: CANCER INVESTIGATION. 2023; Vol. , Issue , pp. -. DOI: 10.1080/07357907.2023.2209638
        PubMed      DOI
    9.Curcumin Enhances the Efficacy of Docetaxel by Promoting Anti-Tumor Immune Response in Head and Neck Squamous Cell Carcinoma

    Author: Sun, Lili; Yao, Xingmei; Liu, Jingmei; Zhang, Yu; Hu, Jian
    Journal: CANCER INVESTIGATION. 2023; Vol. , Issue , pp. -. DOI: 10.1080/07357907.2023.2194420
        PubMed      DOI
    10.Conversion Surgery for Unresectable Advanced Gastric Cancer: A Systematic Review and Meta-Analysis.

    Author: Du R1, Hu P2, Liu Q3, Zhang J2.
    Journal: Cancer Invest. 2019;37(1):16-28. doi: 10.1080/07357907.2018.1551898. Epub 2019 Jan 11.
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144873.20
    NATURE REVIEWS DRUG DISCOVERY289137.40
    LANCET700148.10
    NEW ENGLAND JOURNAL OF MEDICINE933145.40
    BMJ-British Medical Journal019.90
    BMJ-British Medical Journal019.90
    Nature Reviews Clinical Oncology12799.40
    Nature Reviews Disease Primers4876.70
    NATURE REVIEWS CANCER396111.90
    NATURE REVIEWS IMMUNOLOGY35193.40
    同分区等级的其他期刊名称 h-index CiteScore
    Energy Material Advances013.80
    Journal of High Energy Astrophysics119.70
    VIEW012.60
    HARVARD BUSINESS REVIEW01.40
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE1086.90
    ACM Transactions on Intelligent Systems and Technology469.30
    Journal of the American Nutrition Association02.50
    TRANSACTIONS OF TIANJIN UNIVERSITY012.50
    Machine Intelligence Research06.70
    Molecular Biomedicine06.30
以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

同领域作者分享投稿经验:共67


    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2024 中国: LetPub上海    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)

    增值电信业务经营许可证:沪B2-20211595    网络文化经营许可证:沪网文[2023]2004-152号

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室